Fri 20'th Jul 2018
Catalyst Biosciences Stock Analysis
Technical stock analysis for Fri 20'th Jul 2018
|Shorts||0.88% ( 2018-06-29 )|
Catalyst Biosciences fell by -4.86% in the last day from $10.91 to $10.38 and has now fallen 6 days in a row. The price has fallen in 6 of the last 10 days and is down by -8.87% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -304 175 shares and in total 760 105 shares bought and sold for approximately $7.89 million.
Catalyst Biosciences lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -56.39% during the next 3 months and, with 90% probability hold a price between $0.43 and $7.38 at the end of this period.
There are few to none technical positive signals at the moment. Catalyst Biosciences holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $11.69 and $15.42. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday July 13, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 31 and the stock is currently not being overbought or oversold
Support & Resistance
Catalyst Biosciences finds support from accumulated volume at $10.37.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.95 between high and low, or 9.48%. For the last week, the stock has had a daily average volatility of 11.91%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Catalyst Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.Click for Top 5 Strong Sell Candidates
|CBIO $10.38 $-0.53(-4.86%)|
CBIO is down $0.53 today, but where's it headed in August?
|Zacks Investment Research is releasing its prediction for CBIO based on the 1-3 month system that more than doubles the S&P 500.
Click here – the CBIO analysis is free »